Together Pharma Ltd (TLV:TGTR)
278.90
+0.60 (0.22%)
Apr 24, 2026, 1:44 PM IDT
Together Pharma Revenue
In the year 2025, Together Pharma had annual revenue of 109.63M ILS with 14.13% growth. Together Pharma had revenue of 46.06M in the half year ending December 31, 2025, with 1.26% growth.
Revenue
109.63M
Revenue Growth
+14.13%
P/S Ratio
0.44
Revenue / Employee
522.04K
Employees
210
Market Cap
48.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.63M | 13.58M | 14.13% |
| Dec 31, 2024 | 96.05M | 5.05M | 5.55% |
| Dec 31, 2023 | 91.01M | 59.78M | 191.42% |
| Dec 31, 2022 | 31.23M | 19.20M | 159.67% |
| Dec 31, 2021 | 12.03M | 803.00K | 7.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.90B |
| Amal Holdings A.D. | 2.18B |
| BrainsWay | 166.49M |
| Evogene | 12.28M |
| Clal Biotechnology Industries | 11.55M |
| Identi Healthcare | 10.93M |
| Almeda Ventures Limited Partnership | 7.86M |